Cancer Pancreatic Cancer

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Pancreatic Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Pancreatic Cancer Projects
--AUSTRIANOVA Biotechnology GmbH
--ArQule Inc
--Bristol-Myers Squibb Company
--Bayer Ag
--Cell Genesys Inc
--Celgene Corporation
--Eli Lilly & Co
--DAIICHI SANKYO COMPANY, LIMITED
--Onyx Pharmaceuticals Inc
--Nuvo Research Inc.
--erly Dimethaid Research Inc.)
--Pharmexa A/S
--PharmaMar
--Roche Holdings Ltd
--Raven biotechnologies, inc.
--SuperGen Inc
--Sanofi-Aventis
--Threshold Pharmaceuticals Inc
--Therion Biologics Corporation
--Wyeth
--WILEX AG

--Top Companies in early stage Pancreatic Cancer Projects
--Alchemgen Therapeutics Inc.
--Active Biotech
--Aphios Corporation
--AmpliMed Corporation
--BioVex Inc
--Archemix Corp.
--D-Pharm Ltd
--Cylene Pharmaceuticals, Inc.
--immatics biotechnologies GmbH
--FibroGen, Inc.
--NOXXON Pharma AG
--multimmune GmbH
--Pharmacyclics Inc
--Patrys Limited
--Raven biotechnologies, inc.
--PharmaMar
--Silence Therapeutics plc
--erly SR Pharma plc)
--Regulon, Inc
--Yissum Research Development Company
--Takeda Pharmaceutical Company Limited

Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View